The Revolving Door: Ex-FDA Regulators Find New Homes at Pharma Giants Like Eli Lilly
Tariff Relief: US Postpones Duties on Singaporean Pharma Amidst Supply Chain Concerns
Trump's Bold New Blueprint: Unveiling Ambitious Plans to Slash Prescription Drug Costs
Rethinking Drug Costs: Trump's Bold Bid to Reshape Pharmaceutical Pricing
Indian Pharma Soars: US BIOSECURE Act Triggers Major Opportunity Shift
White House Shelves Generic Drug Tariffs, Paving the Way for Indian Pharma's Continued Success
NHRC Demands Answers Amidst Tragic Cough Syrup Deaths: A Call for Accountability
Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?
A Bitter Truth: India's Pharmaceutical Industry Under Scrutiny Amidst Global Cough Syrup Tragedies
The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing
The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines
Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape
Trump's Pfizer Deal: A 'Devastating' Blow to PBMs and Insurers, Warns LaMattina
TrumpRx Unveils Groundbreaking Platform to Dramatically Cut Prescription Drug Costs
Pfizer's Bold New Chapter: Shares Soar as Pharma Giant Commits to Sweeping US Drug Price Cuts
Trump's Trade Winds: Navigating the Storm for India's Pharma Giants
Unveiling the Conflict: Trump's Anti-Tylenol Advisor and Hidden Payments from Competitors
Trump's Tariff Gamble: Experts Unpack the Real Cost of Pharma Duties
US Tariffs Threaten India's Generic Pharma Powerhouse: Himachal Manufacturers Sound Alarm
Trump's Tariff Threat: A Double-Edged Sword for India's Pharma Manufacturing Ambitions
Trump's Tariff Threat Looms: How India's Pharma Giants Brace for a 100% Import Duty Shake-up
Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis
India's Pharmaceutical Powerhouse Under Siege: Navigating Trump's Tariff Tempest
Trump's Bold Tariff Escalation: 100% on Pharma Imports, Expanded Duties on Furniture & Heavy Trucks
A New Frontier in Health: RFK Jr. Challenges Conventional Wisdom at the UN on Chronic Disease
The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability
Dr. Evelyn Jarvis Unmasks 'Tylenol Briefing' as a Trove of Pseudoscience, Sparking Public Outcry
Kenvue Stock Under Siege: Trump's Tylenol Warning Rekindles Autism Lawsuits, But Retail Bulls Hold Firm
Indian Healthcare Boom: Rs 13,000 Cr IPO Wave on the Horizon
Indian Pharma Sector Poised for Massive Rs 45,000 Crore Investment Boom by FY26, ICRA Reports
The Ozempic Effect: How Weight-Loss Drugs Are Reshaping Economies and Creating Thousands of Jobs
Novo Nordisk's Strategic Overhaul: 9,000 Job Cuts to Propel Future Dominance
Trump's Bold Play: Mandating Sweeping Side Effect Disclosures in Drug Ads
Unveiling RFK Jr.'s Audacious Vision: The 'Make America Healthy Again' Blueprint
RFK Jr.'s 'Make America Healthy Again': Unpacking the Vision for Public Health
Unlocking Breakthroughs: Cell Lysis and Disruption Market Set to Explode Past $10.9 Billion by 2032
The WHO's Bold Stance: Backing Weight-Loss Wonders While Championing Affordable Access
Fiery Senate Showdown: RFK Jr. Ignites Heated Debate on Vaccine Access with Bipartisan Senators
Gilead's Visionary Expansion: Foster City Emerges as a Global Biotech Epicenter
India's Pharma Marketing Rules Get a Mandatory Makeover: Simplified Compliance, But What About the Finer Print?
Trump Ignites Debate: Demands Drugmakers Justify COVID-19 Vaccine Claims
Trump's Bold Drug Tariff: A Double-Edged Sword for American Healthcare?
India's 'Pharmacy of the World' Title at Risk: Urgent GST Reforms Needed for Pharma Exports